| Evaluated Parameters | 1st check-up (N = 395) | 2nd check-up (N = 162) | 3rd check-up (N = 79) | Total of controls (N = 636) |
| Number of patients -n (%) | 395 (100) | 97 (59.9) | 18 (22.8) | 510 (80.2) |
| Lost to follow-up -n (%) | 0 (0.0) | 65 (40.1) | 61 (77.2) | 126 (19.8) |
| Imaging at scheduled time -n (%) | 108 (27.3) | 32 (19.8) | 12 (15.2) | 152 (23.9) |
| Imaging at delayed time -n (%) | 287 (72.7) | 65 (40.1) | 6 (7.6) | 358 (56.3) |
| Stable BIRADS-3 lesions -n (%) | 162 (41.0) | 79 (48.8) | 0 (0.0) | 241 (37.9) |
| Graded as BIRADS-2 -n (%) | 124 (31.4) | 12 (7.4) | 18 (22.8) | 154 (24.2) |
| Upgraded to BIRADS-4 -n (%) | 109 (27.6) | 6 (3.7) | 0 (0.0) | 115 (18.1) |
| Underwent biopsy | 101 (25.6) | 6 (3.7) | 0 (0.0) | 107 (16.8) |
| Cancers diagnosed | 41 (10.4) | 2 (1.2) | 0 (0.0) | 43 (6.8) |
| Underwent mastectomies | 33 (8.4) | 2 (1.2) | 0 (0.0) | 35 (5.5) |